There were 15 abstracts presented describing radial access and intervention during the American College of Cardiology (ACC) and i2 Summit meeting in April in New Orleans. The abstracts focused on some of the most burning issues in current radial research.

May 17, 2011 - Medrad Inc., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocathtechnology. The Cotavance catheter is used in percutaneous interventions for the treatment of peripheral arterial disease (PAD) and is approved for balloon dilation of stenotic lesions in the iliac and infrainguinal arteries while applying paclitaxel to the vessel wall to inhibit restenosis. Medrad Interventional has started selling its Cotavance catheter in countries where it has already received regulatory approval, including select European and Middle East countries. The announcement was made in conjunction with the Congress of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) in Paris.


The RIVAL trial shows there is no difference in rates of composite death, myocardial infarction, stroke or major bleeding between radial access and femoral access strategies, but radial access decreased major vascular complications.

May 18, 2011 - Jasbir Sra, M.D., and Tanvir Bajwa, M.D., are the first in Wisconsin to implant a new device in a patient’s heart that may reduce strokes in individuals suffering from atrial fibrillation, a common heart arrhythmia. This minimally invasive procedure was part of a clinical trial taking place at Aurora St. Luke’s Medical Center.

May 18, 2011 - Arstasis is pleased to announce the U.S. launch of its latest commercial product - the Axera Access Device. The Axera Device enhances insertability into the femoral artery and overall procedural usage while continuing to deliver the clinical benefits of the implant-free arstaotomy procedure.


As medicine continues its march away from open surgical procedures to minimally invasive and transcatheter treatments, the cath lab has opened up to new treatment areas beyond the coronaries. Peripheral artery disease (PAD) in the legs has traditionally been the territory of vascular surgeons, but there has been a major transition to transcatheter PAD procedures in the past 10 years, blurring the lines between surgeons and interventionalists.

May 18, 2011 - The Society for Imaging Informatics in Medicine (SIIM) announces tools and training to help medical informaticsprofessionals stay competitive in a rapidly changing environment. SIIM will provide fundamental, up-to-date education and solutions essential for imaging informatics professionals (IIPs) and their organizations at the society's 2011 annual meeting, June 2-5, in Washington, D.C./National Harbor, Md.

May 16, 2011 - Cordis announces the launch in Europe of Radial Solutions, a complete portfolio for transradial interventions. New to the portfolio is the Cordis Radialsource Transradial Access Kit. Radialsource Transradial Sheaths are designed to provide physicians with atraumatic and smooth access to the radial artery during diagnostic and interventional procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now